Anzeige
Mehr »
Login
Donnerstag, 27.06.2024 Börsentäglich über 12.000 News von 684 internationalen Medien
Der Schlüssel zur Technologie der Zukunft und Ihre einmalige MEGA-Investment-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
362 Leser
Artikel bewerten:
(2)

Registration Call for MarketsandMarkets 4th Annual Next Gen Microbiome and Probiotics Conference

Know about new microbiome findings, branding, and marketing of probiotics, effective translation from R&D to commercialization

CHICAGO, June 15, 2022 /PRNewswire/ -- The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product and drug development, various small innovative players are operating in the market. However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress.

MarketsandMarkets_Logo

The 4th Annual Next Gen Microbiome and Probiotics Conference which will be held on 16th-17th June 2022 at Double Tree by Hilton - Mission Valley, San Diego, USA, will give the attendees an opportunity to connect with biotech, pharma, academicians, and investors, discussing the most ingenious research and technological advances. They will also get access to some interesting key sessions on applying new microbiome findings, regulatory updates, branding, and marketing of probiotics along with discussion on effective translation from R&D to commercialization.

This event will bring together professionals in healthcare, therapeutics, universities, researchers, and scientists to discuss cutting-edge developments in microbiome and probiotics.

Featured Speakers:

  1. Julius Goepp, Founder, CEO, Scaled Microbiomics
  2. Emily Stein, CEO, Primal Health Inc.
  3. Nicole M. Scott, CEO and Founder, Cybele Microbiome
  4. Yug Varma, CEO, Phi Therapeutics
  5. Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech
  6. Seth D. Crosby, Director, Research Collaborations, Washington University School of Medicine
  7. Oliver Worsley, CEO, Sequential Skin
  8. Larry Weiss, CEO & Founder, Symbiome
  9. Sandrine Miller-Montgomery, Co-Founder, President and CEO, Micronoma

Registration link - https://events.marketsandmarkets.com/4th-annual-marketsandmarkets-next-gen-microbiome-and-probiotics-conference/register

About MarketsandMarkets

MarketsandMarkets is a revenue impact and advisory firm, providing quantified B2B research to over 10,000 clients worldwide. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem - by providing actionable insights on disruptive trends and identifying blind spots, assessing competitive landscape in real-time, and analyzing how these trends are impacting not only customers but also their customers as well. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

For further insights, contact:
Charu Raizada
VP, Corporate Communications
MarketsandMarkets INC.
Email: charu.raizada@MarketsandMarkets.com
USA: +1-888-600-6441
Visit Our Website: https://www.MarketsandMarkets.com

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2022 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.